These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12389670)

  • 1. Elevated amniotic fluid ferritin levels are associated with inflammation-related pregnancy loss following mid-trimester amniocentesis.
    Ramsey PS; Andrews WW; Goldenberg RL; Tamura T; Wenstrom KD; Johnston KE
    J Matern Fetal Neonatal Med; 2002 May; 11(5):302-6. PubMed ID: 12389670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial invasion and preterm delivery.
    Daskalakis G; Thomakos N; Papapanagiotou A; Papantoniou N; Mesogitis S; Antsaklis A
    BJOG; 2009 Dec; 116(13):1743-8. PubMed ID: 19906019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss.
    Chaiworapongsa T; Romero R; Tolosa JE; Yoshimatsu J; Espinoza J; Kim YM; Kim JC; Bujold E; Kalache K; Edwin S
    J Matern Fetal Neonatal Med; 2002 Sep; 12(3):159-64. PubMed ID: 12530612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery.
    Yoon BH; Oh SY; Romero R; Shim SS; Han SY; Park JS; Jun JK
    Am J Obstet Gynecol; 2001 Nov; 185(5):1162-7. PubMed ID: 11717651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
    Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
    J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection.
    Hillier SL; Witkin SS; Krohn MA; Watts DH; Kiviat NB; Eschenbach DA
    Obstet Gynecol; 1993 Jun; 81(6):941-8. PubMed ID: 8497360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of infection and their relationship to preterm delivery.
    Foulon W; Van Liedekerke D; Demanet C; Decatte L; Dewaele M; Naessens A
    Am J Perinatol; 1995 May; 12(3):208-11. PubMed ID: 7612097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome.
    Pressman EK; Thornburg LL; Glantz JC; Earhart A; Wall PD; Ashraf M; Pryhuber GS; Woods JR
    Am J Obstet Gynecol; 2011 Feb; 204(2):155.e1-7. PubMed ID: 20950789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-trimester amniotic fluid C-reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour.
    Borna S; Mirzaie F; Abdollahi A
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):400-3. PubMed ID: 19694695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery.
    Thomakos N; Daskalakis G; Papapanagiotou A; Papantoniou N; Mesogitis S; Antsaklis A
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):147-51. PubMed ID: 19945777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High interleukin-16 concentrations in the early second trimester amniotic fluid: an independent predictive marker for preterm birth.
    Hsu TY; Lin H; Lan KC; Ou CY; Tsai CC; Cheng BH; Yang KD; Wong YH; Hung TH; Hsiao PY; Kao HF
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):285-9. PubMed ID: 23020666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide: a clinically important amniotic fluid marker to distinguish between intra-amniotic mycoplasma and non-mycoplasma infections.
    Hsu CD; Aversa KR; Lu LC; Meaddough E; Jones D; Bahado-Singh RO; Copel JA; Lee IS
    Am J Perinatol; 1999; 16(4):161-6. PubMed ID: 10458527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of infection and inflammation in the amniotic fluid: therapeutic contribution of amniocentesis].
    Le Bouar G; Lassel L; Poulain P
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S52-6. PubMed ID: 12454626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-trimester maternal serum and amniotic fluid biomarkers for the prediction of preterm delivery and intrauterine growth retardation.
    Ozgu-Erdinc AS; Cavkaytar S; Aktulay A; Buyukkagnici U; Erkaya S; Danisman N
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1540-6. PubMed ID: 24888913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation levels of cytokines in amniotic fluid of women with intrauterine infection in the early second trimester.
    Suzuki Y; Yamamoto T; Kojima K; Tanemura M; Tateyama H; Suzumori K
    Fetal Diagn Ther; 2006; 21(1):45-50. PubMed ID: 16354974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss.
    Wenstrom KD; Andrews WW; Tamura T; DuBard MB; Johnston KE; Hemstreet GP
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):830-3. PubMed ID: 8885730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy.
    Horowitz S; Mazor M; Romero R; Horowitz J; Glezerman M
    J Reprod Med; 1995 May; 40(5):375-9. PubMed ID: 7608879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome.
    Nguyen DP; Gerber S; Hohlfeld P; Sandrine G; Witkin SS
    J Perinat Med; 2004; 32(4):323-6. PubMed ID: 15346817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentrations of interleukin-6 in intra-amniotic infection with Ureaplasma urealyticum in asymptomatic women during genetic amniocentesis.
    Bashiri A; Horowitz S; Huleihel M; Hackmon R; Dukler D; Mazor M
    Acta Obstet Gynecol Scand; 1999 May; 78(5):379-82. PubMed ID: 10326880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.